Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Wyeth-Ayerst has option to license Teikoku Hormone's antiandrogen

May 7, 1998

FDA clears CRYOcare surgical system to treat BPH

May 4, 1998

Cheung seeks FDA approval to begin testing of BPH treatment system

April 30, 1998

Takeda presents agents inhibiting PDGF activity for renal, cardiovascular disorders

April 29, 1998

New vasopressin V2 antagonists in development at Wakamoto

April 23, 1998

Synthelabo discloses new benzimidazoles for urinary incontinence

April 21, 1998

Alza acquires Canadian rights to Ditropan

April 20, 1998

Agents for urinary incontinence and IBS in development at Pharmacia & Upjohn

April 17, 1998

New agents for BPH emerge from Synaptic/Merck & Co. collaboration

April 9, 1998

Expanded indication approved for Proscar

April 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...